San Francisco, 17
September 2018: The global smart syringes market is expected to reach USD 10.2 billion in 2024,
according to a new report by Grand View Research, Inc. In 2015, Some key
factors driving the market include the rise in the patient population, the
increasing number of needle stick injuries, and the spread of diseases due to
unhygienic injection practices.
The injection practices
and healthcare delivery standards are not uniform across the globe. The use of
disposable syringes has been strongly advocated by various healthcare
organizations across different countries; however, adherence to the patient
safety guidelines is not adequately implemented in the LMIC (Low and Middle
Income Countries).
As per the WHO records,
the re-usage of syringes has boosted the infection cases of Ebola, malaria,
Marburg virus, HIV, hepatitis, and other diseases in LMIC; these countries have
been suffering with a huge infectious diseases burden due to the high transmission
rates of blood-borne virus infections. Increasing awareness regarding the usage
of smart syringes with safety mechanisms amongst the patients and the
healthcare providers is anticipated to fuel the expansion of the smart syringes
market over the forecast period.
As per the data
published by the U.S. Occupational Safety and Health Administration (OSHA),
nearly 5.6 million workers in the healthcare sector are at a high risk of
occupational exposure to blood-borne pathogens, mainly on account of needle
stick injuries and other metal injuries. The data also indicates that on an
average 1,000 injuries occur per day in the U.S. hospitals, which translates to
385,000 needle stick and other injuries per year.
Some previously reported
outbreaks due to the re-use of syringes include the following:
·
In 2007, hepatitis C outbreak in Nevada,
U.S.
·
In 2009, more than 400 people were infected
with Hepatitis B in Gujarat, India
·
In 2014, a group of more than 200
people(children and adults) living near Battambang, Cambodia, tested positive
for HIV
Hence, in order to
improve the healthcare outcomes and reduce the burden of infections, the
healthcare practitioners and hospitals are expected to adopt the usage of smart
syringes,which would significantly boost the smart syringes market over the
forecast period.
Access Research Report
of Smart Syringes Market @
www.grandviewresearch.com/industry-analysis/smart-syringes-market
Further key findings from the study suggest:
· In 2015, the auto-disable syringes segment
dominated the smart syringes market with revenue of over USD 3.0 billion. The
established presence of the auto-disable syringes in the market is one of the
crucial reasons for its high share.
· The passive safety syringes segment is
expected to emerge as the fastest growing market during the forecast period
· North America accounted for the largest
share in 2015 on account of very high healthcare standards, the presence of
well-developed hospital and primary healthcare networks, high patient
awareness, and the rising demand for sophisticated drug delivery techniques.
· Asia Pacific is identified as the most
lucrative market. Increase in the disease burden, the rising population levels,
and the growing demand for vaccination are the key market drivers in this
region. Furthermore, high investments to improve the patient care services and
to curb the risk of needle stick infections are expected to spur the smart
syringes market over the forecast period.
· Some key players of the market include
Medtronic Plc (Covidien), Terumo Medical Corporation, Braun Melsungen AG,
Unilife Corporation, Becton, Dickinson and Co., Revolutions Medical
Corporation, Baxter International, Inc., Retractable Technologies, Inc., and
Smiths Group plc.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has
segmented the smart syringes market by product, application, end-use, and
region:
Smart Syringes Product Outlook, (USD Million, 2013 -
2024)
·
Auto-disable syringes
·
Active safety syringes
·
Passive safety syringes
Smart Syringes Application Outlook, (USD Million,2013 -
2024)
·
Drug delivery
·
Vaccination
·
Blood specimen collection
Smart Syringes End-Use Outlook, (USD Million,2013 - 2024)
·
Hospitals and HMOs
·
Diabetic patients
·
Family practices (Physicians)
·
Psychiatrists
·
Others
Smart Syringes Regional Outlook, (USD Million, 2013 -
2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
o
Mexico
·
MEA
o South Africa
Access Press Release of
Smart Syringes Market@ www.grandviewresearch.com/press-release/global-smart-syringes-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment